Literature DB >> 24360370

Single-dose radical cure of Plasmodium vivax: a step closer.

Ric N Price1, François Nosten2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24360370      PMCID: PMC4627505          DOI: 10.1016/S0140-6736(13)62672-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Primaquine therapy for malaria.

Authors:  J Kevin Baird; Stephen L Hoffman
Journal:  Clin Infect Dis       Date:  2004-10-12       Impact factor: 9.079

2.  Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.

Authors:  Douglas S Walsh; Polrat Wilairatana; Douglas B Tang; D Gray Heppner; Thomas G Brewer; Srivicha Krudsood; Udomsak Silachamroon; Weerapong Phumratanaprapin; Duangsuda Siriyanonda; Sornchai Looareesuwan
Journal:  Clin Infect Dis       Date:  2004-09-24       Impact factor: 9.079

3.  Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.

Authors:  Inge Sutanto; Bagus Tjahjono; Hasan Basri; W Robert Taylor; Fauziah A Putri; Rizka A Meilia; Rianto Setiabudy; Siti Nurleila; Lenny L Ekawati; Iqbal Elyazar; Jeremy Farrar; Herawati Sudoyo; J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

Review 4.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

5.  Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.

Authors:  Alejandro Llanos-Cuentas; Marcus V Lacerda; Ronnatrai Rueangweerayut; Srivicha Krudsood; Sandeep K Gupta; Sanjay K Kochar; Preetam Arthur; Nuttagarn Chuenchom; Jörg J Möhrle; Stephan Duparc; Cletus Ugwuegbulam; Jörg-Peter Kleim; Nick Carter; Justin A Green; Lynda Kellam
Journal:  Lancet       Date:  2013-12-19       Impact factor: 79.321

Review 6.  Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.

Authors:  Ric N Price; Sarah Auburn; Jutta Marfurt; Qin Cheng
Journal:  Trends Parasitol       Date:  2012-10-05

7.  The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.

Authors:  W Peters; B L Robinson; W K Milhous
Journal:  Ann Trop Med Parasitol       Date:  1993-12

8.  A long neglected world malaria map: Plasmodium vivax endemicity in 2010.

Authors:  Peter W Gething; Iqbal R F Elyazar; Catherine L Moyes; David L Smith; Katherine E Battle; Carlos A Guerra; Anand P Patil; Andrew J Tatem; Rosalind E Howes; Monica F Myers; Dylan B George; Peter Horby; Heiman F L Wertheim; Ric N Price; Ivo Müeller; J Kevin Baird; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

Review 9.  Determinants of relapse periodicity in Plasmodium vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

Review 10.  Primaquine radical cure of Plasmodium vivax: a critical review of the literature.

Authors:  George K John; Nicholas M Douglas; Lorenz von Seidlein; Francois Nosten; J Kevin Baird; Nicholas J White; Ric N Price
Journal:  Malar J       Date:  2012-08-17       Impact factor: 2.979

View more
  9 in total

Review 1.  Malaria medicines: a glass half full?

Authors:  Timothy N C Wells; Rob Hooft van Huijsduijnen; Wesley C Van Voorhis
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

2.  The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei.

Authors:  Luis Carvalho; Marta Martínez-García; Ignacio Pérez-Victoria; José Ignacio Manzano; Vanessa Yardley; Francisco Gamarro; José M Pérez-Victoria
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

3.  Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.

Authors:  Brittney M J Potter; Lisa H Xie; Chau Vuong; Jing Zhang; Ping Zhang; Dehui Duan; Thu-Lan T Luong; H M T Bandara Herath; N P Dhammika Nanayakkara; Babu L Tekwani; Larry A Walker; Christina K Nolan; Richard J Sciotti; Victor E Zottig; Philip L Smith; Robert M Paris; Lisa T Read; Qigui Li; Brandon S Pybus; Jason C Sousa; Gregory A Reichard; Sean R Marcsisin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria.

Authors:  Margaret A Phillips; Julie Lotharius; Kennan Marsh; John White; Anthony Dayan; Karen L White; Jacqueline W Njoroge; Farah El Mazouni; Yanbin Lao; Sreekanth Kokkonda; Diana R Tomchick; Xiaoyi Deng; Trevor Laird; Sangeeta N Bhatia; Sandra March; Caroline L Ng; David A Fidock; Sergio Wittlin; Maria Lafuente-Monasterio; Francisco Javier Gamo Benito; Laura Maria Sanz Alonso; Maria Santos Martinez; Maria Belen Jimenez-Diaz; Santiago Ferrer Bazaga; Iñigo Angulo-Barturen; John N Haselden; James Louttit; Yi Cui; Arun Sridhar; Anna-Marie Zeeman; Clemens Kocken; Robert Sauerwein; Koen Dechering; Vicky M Avery; Sandra Duffy; Michael Delves; Robert Sinden; Andrea Ruecker; Kristina S Wickham; Rosemary Rochford; Janet Gahagen; Lalitha Iyer; Ed Riccio; Jon Mirsalis; Ian Bathhurst; Thomas Rueckle; Xavier Ding; Brice Campo; Didier Leroy; M John Rogers; Pradipsinh K Rathod; Jeremy N Burrows; Susan A Charman
Journal:  Sci Transl Med       Date:  2015-07-15       Impact factor: 17.956

Review 5.  Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.

Authors:  Kevin Baird
Journal:  Pathog Glob Health       Date:  2015-05       Impact factor: 2.894

6.  Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.

Authors:  Ronnatrai Rueangweerayut; Germana Bancone; Emma J Harrell; Andrew P Beelen; Supornchai Kongpatanakul; Jörg J Möhrle; Vicki Rousell; Khadeeja Mohamed; Ammar Qureshi; Sushma Narayan; Nushara Yubon; Ann Miller; François H Nosten; Lucio Luzzatto; Stephan Duparc; Jörg-Peter Kleim; Justin A Green
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

7.  Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malaria.

Authors:  Karan Uppal; Jorge L Salinas; Wuelton M Monteiro; Fernando Val; Regina J Cordy; Ken Liu; Gisely C Melo; Andre M Siqueira; Belisa Magalhaes; Mary R Galinski; Marcus V G Lacerda; Dean P Jones
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

Review 8.  Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.

Authors:  Kamala Thriemer; Benedikt Ley; Albino Bobogare; Lek Dysoley; Mohammad Shafiul Alam; Ayodhia P Pasaribu; Jetsumon Sattabongkot; Elodie Jambert; Gonzalo J Domingo; Robert Commons; Sarah Auburn; Jutta Marfurt; Angela Devine; Mohammad M Aktaruzzaman; Nayeem Sohel; Rinzin Namgay; Tobgyel Drukpa; Surender Nath Sharma; Elvieda Sarawati; Iriani Samad; Minerva Theodora; Simone Nambanya; Sonesay Ounekham; Rose Nanti Binti Mudin; Garib Da Thakur; Leo Sora Makita; Raffy Deray; Sang-Eun Lee; Leonard Boaz; Manjula N Danansuriya; Santha D Mudiyanselage; Nipon Chinanonwait; Suravadee Kitchakarn; Johnny Nausien; Esau Naket; Thang Ngo Duc; Ha Do Manh; Young S Hong; Qin Cheng; Jack S Richards; Rita Kusriastuti; Ari Satyagraha; Rintis Noviyanti; Xavier C Ding; Wasif Ali Khan; Ching Swe Phru; Zhu Guoding; Gao Qi; Akira Kaneko; Olivo Miotto; Wang Nguitragool; Wanlapa Roobsoong; Katherine Battle; Rosalind E Howes; Arantxa Roca-Feltrer; Stephan Duparc; Ipsita Pal Bhowmick; Enny Kenangalem; Jo-Anne Bibit; Alyssa Barry; David Sintasath; Rabindra Abeyasinghe; Carol H Sibley; James McCarthy; Lorenz von Seidlein; J Kevin Baird; Ric N Price
Journal:  Malar J       Date:  2017-04-05       Impact factor: 2.979

9.  Streamlined SMFA and mosquito dark-feeding regime significantly improve malaria transmission-blocking assay robustness and sensitivity.

Authors:  Tibebu Habtewold; Sofia Tapanelli; Ellen K G Masters; Astrid Hoermann; Nikolai Windbichler; George K Christophides
Journal:  Malar J       Date:  2019-01-25       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.